Reduced Asthma Exacerbations and Asthma-Related Healthcare Resource Use with Omalizumab from the Real-World PROSPERO Study

被引：0
|
作者：
Casale, Thomas B. [1 ]
Iqbal, Ahmar [2 ]
Dang, Joseph [3 ]
Yang, Ming [3 ]
Rajput, Yamina [3 ]
机构：
[1] Univ S Florida, Morsani Coll Med, Tampa, FL USA
[2] Genentech Inc, San Francisco, CA USA
[3] Genentech Inc, San Francisco, CA 94080 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2018.12.303
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
300
引用
收藏
页码：AB99 / AB99
页数：1
相关论文
共 50 条
  • [1] Treatment Response To Omalizumab And Reduced Asthma Exacerbations And Asthma-Related Healthcare Resource Use From The Real-World PROSPERO Study
    Luskin, Allan
    Rajput, Yaminah
    Haselkorn, Tmirah
    Yang, Ming
    Dang, Joseph
    Chipps, Bradley
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB21 - AB21
  • [2] EFFECT OF OMALIZUMAB IN ASTHMA PATIENTS BY NUMBER OF ASTHMA-RELATED AND ALLERGIC COMORBIDITIES IN PROSPERO
    Chen, M.
    Choo, E.
    Haselkorn, T.
    Yoo, B.
    Raut, P.
    Pazwash, H.
    Millette, L.
    Holweg, C.
    Hudes, G.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S41 - S41
  • [3] A REAL-WORLD ASSESSMENT OF ASTHMA EXACERBATIONS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Panettieri, R., Jr.
    Corren, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S52 - S53
  • [4] Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
    Casale, Thomas B.
    Luskin, Allan T.
    Busse, William
    Zeiger, Robert S.
    Trzaskoma, Benjamin
    Yang, Ming
    Griffin, Noelle M.
    Chipps, Bradley E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (01): : 156 - +
  • [5] Patterns of Healthcare Resource Use and Costs for Patients with Severe Asthma-Related Exacerbations in Brazilian Private System
    de Veras, B. M. G.
    Saturnino, L. T.
    Alves, D.
    dos Santos, F. M.
    Paloni, E.
    Rodrigues, S.
    Mello Sylos Neto, H.
    Guariente, M. S.
    Viana, K.
    Alfonso-Cristancho, R.
    Soares, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [6] Predictors of Asthma Control and Exacerbations: A Real-World Study
    Racine, Genevieve
    Forget, Amelie
    Moullec, Gregory
    Jiao, Tianze
    Blais, Lucie
    Lemiere, Catherine
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (07): : 2802 - +
  • [7] Impact Of Omalizumab On All-Cause And Asthma-Related Healthcare Resource Utilization In Patients With Moderate Or Severe Persistent Asthma
    Turner, S. J.
    Nazareth, T.
    Raimundo, K.
    Zhou, H.
    Ortiz, B.
    Yu, T. -C.
    Li, L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [8] Asthma-Related Healthcare Resource Use And Costs In Patients With Documented Food Allergies
    Seetasith, Arpamas
    Sindher, Sayantani
    Boudreau, Denise
    Liu, Yutong
    Gupta, Sachin
    Ciaccio, Christina
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB186 - AB186
  • [9] Asthma-related emergency admissions and associated healthcare resource use in Alberta, Canada
    Mayers, Irvin
    Randhawa, Arsh
    Qian, Christina
    Talukdar, Manisha
    Soliman, Mena
    Jayasingh, Pramoda
    Johnston, Karissa
    Bhutani, Mohit
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [10] Decreased Exacerbations and Improvement in Asthma Symptom Control in Asthma COPD Overlap Treated With Omalizumab: Data From the Prospero Cohort Study
    Hanania, Nicola
    Chipps, Bradley
    Griffin, Noelle
    Trzaskoma, Benjamin
    Iqbal, Ahmar
    Casale, Thomas
    [J]. CHEST, 2017, 152 (04) : 776A - 776A
12345